Steven Mark Sorscher, M.D.
Professor, Hematology & Oncology
Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms; Mutation; Antineoplastic Agents
Reclassifying HER2-equivocal disease [letter]. Sorscher S.. Breast Cancer Res Treat. 2018;167(3):823.
Clinical trials in oncology and defining benefit [letter]. Sorscher S.. Oncologist. 2018;23(1):135.
Ascertainment bias and estimating penetrance [letter]. Sorscher S.. JAMA Oncol. 2018;4(4):587.
Expanding definitions of HER2 positivity [letter]. Sorscher S.. Mod Pathol. 2018;31(4):685.
The importance of distinguishing sporadic cancers from those related to cancer predisposing germline mutations. Sorscher S.. Oncologist. 2018;():.
Estimating risk using multi-gene panel testing; do negative results change the risk? [letter]. Sorscher SM.. J Hum Genet. 2017;62(2):339.
Pathological complete response as a surrogate endpoint [letter]. Sorscher S.. Breast. 2017;33():202.
The significance of invasive breast cancer associated with ductal carcinoma in situ (DCIS) compared with cancer without associated DCIS [letter]. Sorscher S.. JAMA Oncol. 2017;3(5):708-709.
Patients with negative multi-gene panel testing: a back to the future paradox? [letter]. Sorscher SM.. Fam Cancer. 2017;16(3):459.
Pembrolizumab in non-small-cell lung cancer [letter]. Sorscher S.. N Engl J Med. 2017;376(10):996-997.
Anxiety and hereditary testing results [letter]. Sorscher S.. J Genet Couns. 2017;26(5):1162-1163.
Treatment options and patient choices on the basis of enhanced pathologic complete response [letter]. Sorscher S.. J Clin Oncol. 2017;35(15):1746.
Current challenges associated with next-generation sequencing of breast cancer [letter]. Sorscher S.. JAMA Oncol. 2017;3(9):1283-1284.
Li-Fraumeni versus Pseudo-Li-Fraumeni syndrome: key insights for interpreting next-generation sequencing reports in patients with suspected cancer predisposition syndromes. Sorscher S, Desnoyers R, Ouyang K, Ramkissoon S.. Oncologist. 2017;22(9):1084-1085.
Mutation frequencies in patients with early-onset colorectal cancer [letter]. Sorscher S.. JAMA Oncol. 2017;3(11):1585.
Letter to the editor: implications of BRAF mutations in dMMR colorectal cancers. Sorscher S.. Curr Treat Options Oncol. 2017;18(9):57.
Next-generation sequencing in order to better characterize a BRCA variant of uncertain significance. Sorscher S, Ramkissoon S.. Case Rep Oncol. 2017;10(2):634-637.
Mechanism of action and clinical impact of ribociclib [letter]. Sorscher S.. Clin Cancer Res. 2017;23(18):5657.
To the editor: predictive markers and precision medicine [letter]. Sorscher S.. J Natl Compr Canc Netw. 2017;15(10):1186.
Genetic/familial high-risk assessment: breast and ovarian [reply to letter]. Sorscher SM, Pilarski R, Daly M.. J Natl Compr Canc Netw. 2016;14(5):.
How important is 'reason' in influencing adjuvant chemotherapy decisions by patients? [letter]. Sorscher S.. Expert Rev Anticancer Ther. 2016;16(9):895.
More pitfalls related to next-generation sequencing (NGS) [letter]. Sorscher S.. Am J Clin Oncol. 2016;39(4):424.
Understanding the significance of mutations in tumor suppressor genes identified using next-generation sequencing: a case report. Sorscher S.. Case Rep Oncol. 2016;9(2):328-330.
Palbociclib and tumor suppressor gene activation [letter]. Sorscher S.. Expert Opin Pharmacother. 2016;17(14):1975.
Next-generation sequencing of tumors to better estimate the clinical significance of non-BRCA germline deleterious mutations [letter]. Sorscher SM.. J Clin Oncol. 2016;34(34):4183.
Are we making personalized cancer care less personalized? [editorial]. Sorscher S.. Front Oncol. 2016;6():220.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Professor, Hematology & Oncology
Gastrointestinal Cancer, Gastrointestinal Oncology, Breast Cancer
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
always very good
Been coming here since 2013 never been disappointed
Dr. Sorscher is a great doctor. I always feel like he's taking the time to do the best for me and what's going on with my situation; I never feel rushed through.
Dr Sorscher has been an advocate for me, a listener to my silly questions, and experienced doctor. He is knowledegable about my situation, does not sit and read off the computer. Helps me maintain good health.
Dr sorschon is brilliant his beside care is superior
I think *Dr. Sorscher is awesome! He's really great. And so is his team. They are all awesome!
very knowledgeable in his field.
I have come from Tennessee, so if they were not way above normal I would stay in my area. I have told people in my area they might consider Wake Forest do to my experience.
*Dr. Sorscher always spends enough time with us to answer questions and explain plan of care.
trust this group with all of my health issues.
best doctor I have ever had in 64 years
Dr. Sorscher and his team are great and are working hard to help me with a prescription medication cost and exploring other options. I appreciate their above and beyond effort!
I would recommend Dr Sorcher to anyone needing an excellent physician.
Professional and explained plan of care thoroughly.
Dr. Sorcher is the best of the best. I submitted a letter more than one year ago about the exemplary care I receive from Dr. Sorcher & his staff, and it remains accurate and true. I could not wish for better care than he provides.
He is knowledgeable, caring, explains all very well. Excellent oncologist.
Dr. Sorscher is very good at explaining and answering questions. I feel he is very competent and knowledgeable and good about explaining so that I understand.
Physician did a good job. I would have like for him to have had time to actually review the scans I brought before talking with me, but I know that is very time consuming.
My provider is very through and spends all the time needed to answer questions and address issues as they arise. Dr. Sorscher is very dedicated to his patients care and its very important to myself and him that he be able to spend the necessary time to address all issues. I don't mind waiting because I know he is spending the time with another patient who needs it that day. Some days I know he needs to spend that extra time with me. He calls me after hours and on weekends if needed to check on issues. I appreciate his dedication to me as a patient. I know he has my best interest at heart.
he did extensive research on my very rare cancer which showed he was truly concerned about me as his patient and how he could help me.
I have the best
they are all incredibly wonderful!
Dr Sorscher's care and concern for me has steadily declined over the last 3 months. During my last visit with him on 7/3/17, his questions were unrelated to my treatment and demonstrated unconcern for me and my care. I will not return.